Cover Image

Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants

ObjectiveCefepime is used to treat severe infections in neonates. Pharmacokinetic data have only been evaluated among preterm neonates and population pharmacokinetic model lacked external validation. Hence, our aim is to obtain the population pharmacokinetic parameters of cefepime with large samplin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yang Zhao (Author), Bu-Fan Yao (Author), Chen Kou (Author), Hai-Yan Xu (Author), Bo-Hao Tang (Author), Yue-E Wu (Author), Guo-Xiang Hao (Author), Xin-Ping Zhang (Author), Wei Zhao (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Developmental Population Pharmacokinetics-Pharmacodynamics of Meropenem in Chinese Neonates and Young Infants: Dosing Recommendations for Late-Onset Sepsis
by: Yue-E Wu, et al.
Published: (2022)

Optimal dose of cefotaxime in neonates with early-onset sepsis: A developmental pharmacokinetic model-based evaluation
by: Zhen-Hai Shang, et al.
Published: (2022)

Population Pharmacokinetic Study of Cefathiamidine in Infants With Augmented Renal Clearance
by: Bin Du, et al.
Published: (2021)

Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study
by: Ting-Yi Su, et al.
Published: (2017)

Cefepime Dosing Requirements in Elderly Patients Attended in the Emergency Rooms
by: Jesus Ruiz-Ramos PhD, et al.
Published: (2022)

Population pharmacokinetic study in children with vascular anomalies: body weight as a key variable in predicting the initial dose and dosing frequency of sirolimus
by: Lin Fan, et al.
Published: (2024)

Developmental Pharmacogenetics of CYP2D6 in Chinese Children: Loratadine as a Substrate Drug
by: Qian Li, et al.
Published: (2021)

Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
by: José C. Álvarez, et al.
Published: (2021)

Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study
by: Hao Liang, et al.
Published: (2024)

A physiologically based pharmacokinetic model of cefepime to predict its pharmacokinetics in healthy, pediatric and disease populations
by: Muhammad Talha Zahid, et al.
Published: (2023)

Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection
by: Zhi LJ, et al.
Published: (2018)

Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance
by: Sixuan Zhao, et al.
Published: (2021)

Phenobarbital Pharmacokinetics and Optimal Dosing of Phenobarbital
by: Safiullah Shareef, et al.
Published: (2018)

Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
by: Chao‐Yang Chen, et al.
Published: (2023)

Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization
by: SiChan Li, et al.
Published: (2022)

Population pharmacokinetics, dosing optimization and clinical outcomes of biapenem in patients with sepsis
by: Dayu Chen, et al.
Published: (2024)

Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy
by: Lu Li, et al.
Published: (2020)

Population pharmacokinetics and dose optimization of magnesium sulfate in Chinese preeclampsia population
by: Jing Deng, et al.
Published: (2024)

Influence of Flunixin on the Disposition Kinetic of Cefepime in Goats
by: Mohamed El-Hewaity
Published: (2014)

Comparison of Cefepime with Piperacillin/Tazobactam Treatment in Patients with Hospital-Acquired Pneumonia
by: Bo-Guen Kim, et al.
Published: (2023)

Population pharmacokinetics and dosing optimization of unbound teicoplanin in Chinese adult patients
by: Wen-Qian Fu, et al.
Published: (2022)

Optimization of Busulfan Dosing Regimen in Pediatric Patients Using a Population Pharmacokinetic Model Incorporating GST Mutations
by: Yuan J, et al.
Published: (2021)

Population pharmacokinetics of buprenorphine and naloxone sublingual combination in Chinese healthy volunteers and patients with opioid use disorder: Model-based dose optimization
by: Meng Gu, et al.
Published: (2023)

Population pharmacokinetic analysis for dose regimen optimization of vancomycin in Southern Chinese children
by: Xianhuan Shen, et al.
Published: (2024)

Continuous Infusion of High Doses of Cefepime in Intensive Care Unit: Assessment of Steady-State Plasma Level and Incidence on Neurotoxicity
by: Vanessa Jean-Michel, et al.
Published: (2022)

Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children
by: Li Q, et al.
Published: (2019)

Physiologically based pharmacokinetic modeling of daptomycin dose optimization in pediatric patients with renal impairment
by: Lingling Ye, et al.
Published: (2022)

Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia
by: Xingchen Bian, et al.
Published: (2024)

Population Pharmacokinetics and Dose Optimization of Ganciclovir in Critically Ill Children
by: SiChan Li, et al.
Published: (2021)

Population pharmacokinetics and dose optimization of ceftazidime in critically ill children
by: Mengting Li, et al.
Published: (2024)

An insight into pharmacokinetics and dose optimization of antimicrobials agents in elderly patients
by: Guanshuang Fu, et al.
Published: (2024)

Population Pharmacokinetics and Dosing Regimen Optimization of Latamoxef in Chinese Children
by: Yang Wang, et al.
Published: (2022)

Application of a Physiologically Based Pharmacokinetic Model to Characterize Time-dependent Metabolism of Voriconazole in Children and Support Dose Optimization
by: Yahui Zhang, et al.
Published: (2021)

Klebsiella pneumoniae Infections in Hospitalized Patients: Characterization of Antibiotic Cross-resistance and Detection of Cefepime Susceptible-dose Dependent (SDD) Strains
by: Gholamreza Pourali Sheshblouki, et al.
Published: (2016)

Impact of Extracorporeal Membrane Oxygenation (ECMO) on Serum Concentrations of Cefepime
by: Christopher J. Destache, et al.
Published: (2024)

Cefepime-Induced Neutropenia: A Case Report and Literature Review
by: Koraysh S, et al.
Published: (2023)

Paradoxical Anticonvulsant Effect of Cefepime in the Pentylenetetrazole Model of Seizures in Rats
by: Dmitry V. Amakhin, et al.
Published: (2020)

Population Pharmacokinetics and Model-Based Dosing Optimization of Teicoplanin in Pediatric Patients
by: Tao Zhang, et al.
Published: (2020)

Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients
by: Miao Zhang, et al.
Published: (2021)

Population pharmacokinetics of valproic acid in children with epilepsy: Implications for dose tailoring when switching from oral syrup to sustained‐release tablets
by: Wei‐Jun Wang, et al.
Published: (2024)